News & Updates
Filter by Specialty:

Screening, treatment for CVD lower in people with mental disorders
Individuals with mental disorders, specifically schizophrenia, receive fewer screening and lower-quality treatment for cardiovascular disease (CVD), reveals a study.
Screening, treatment for CVD lower in people with mental disorders
03 Oct 2021
Existing risk scores not enough to predict AF outcomes after pulmonary vein isolation
Currently available risk scores are unreliable for predicting recurrent atrial fibrillation (AF) after initial radiofrequency pulmonary vein isolation, a new study has found.
Existing risk scores not enough to predict AF outcomes after pulmonary vein isolation
02 Oct 2021
Major infections after PCI, CABG do not affect very long-term survival
While major infections worsen 5-year survival after percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) for coronary artery disease, no detrimental effects on mortality are observed thereafter, suggesting that its impact subsides after 5 years, a recent study has found.
Major infections after PCI, CABG do not affect very long-term survival
01 Oct 2021
The role of apixaban in managing venous thromboembolism
Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), carries a significant morbidity risk. Risk factors for VTE include surgery, hospitalization, pregnancy, contraceptive use, older age, overweight, and obesity. Dr Lee Yuh Shan, a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore, explains how newer drugs such as apixaban (Eliquis, Pfizer) address the challenges posed by conventional VTE management therapies.